Aimei Health Technology Co., Ltd (AFJK) Earnings History
Profitable3 years of earnings data (2023–2025) · Positive TTM net income
Loading earnings history...
Aimei Health Technology Co., Ltd (AFJK) Earnings Overview
As of June 23, 2026, Aimei Health Technology Co., Ltd (AFJK) reported trailing twelve-month net income of $920,546, reflecting -39.3% year-over-year growth. The company earned $0.88 per diluted share over the past four quarters.
Looking at the long-term picture, AFJK's historical earnings data spans multiple years. The company achieved its highest annual net income of $3M in fiscal 2024.
Aimei Health Technology Co., Ltd maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including CANG (-$2.46B net income, -65.8% margin), BTBT (-$169M net income, -70.7% margin), CLOV (-$57M net income, -4.4% margin), AFJK has comparable earnings metrics. Compare AFJK vs CANG →
AFJK Earnings vs Peers
Earnings metrics vs comparable public companies
AFJK Historical Earnings Data (2023–2025)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1M | -58.5% | $-835,759 | $0.17 | - | - |
| 2024 | $3M | +1389.0% | -$1M | $0.28 | - | - |
| 2023 | $171,389 | - | $-28,459 | $0.02 | - | - |
Download Data
Export AFJK earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AFJK — Frequently Asked Questions
Quick answers to the most common questions about buying AFJK stock.
What is AFJK earnings per share (EPS)?
AFJK trailing twelve-month (TTM) diluted EPS is $0.88, reflecting -39.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2023 to 2025 is available in the table on this page.
What is Aimei Health Technology Co., Ltd's net income?
Aimei Health Technology Co., Ltd (AFJK) trailing twelve-month net income is $920546.00 as of 2025. Earnings declined -39.3% year-over-year. Aimei Health Technology Co., Ltd has been profitable for 3 consecutive years.
Is AFJK profitable?
Yes, AFJK is profitable with a TTM net income of $920546.00 and a net profit margin of N/A. Aimei Health Technology Co., Ltd has generated profits for 3 consecutive years.
What is AFJK's earnings growth rate?
AFJK compound annual EPS growth rates (CAGR): 1-Year: -39.3%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2023 to 2025.
What are AFJK's profit margins?
Aimei Health Technology Co., Ltd net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is +2.6%.
Is AFJK growing earnings?
AFJK earnings are declining — EPS fell -39.3% year-over-year. TTM net income dropped to $920546.00. This contrasts with the 5-year CAGR of N/A.
What was AFJK's best earnings year?
Aimei Health Technology Co., Ltd's highest annual net income on record is $3M, achieved in fiscal year 2024. Earnings history on this page spans 2023 to 2025 and includes all annual and quarterly figures.
What were AFJK's earnings last quarter?
AFJK's most recent reported quarter was Q1 2026. Net income was $45440.00 with diluted EPS of $0.01. For a full breakdown of all quarters, see the quarterly earnings table on this page.